1 / 113

Association of Reproductive Health Professionals www.arhp.org

Options for Therapeutic Abortion: Manual Vacuum Aspiration and Medication Management. Association of Reproductive Health Professionals www.arhp.org. Expert Medical Advisory Committee. Herbert P. Brown, MD Michelle Forcier, MD, MPH Emily Godfrey, MD, MPH Marji Gold, MD

thetis
Télécharger la présentation

Association of Reproductive Health Professionals www.arhp.org

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Options for Therapeutic Abortion: Manual Vacuum Aspiration and Medication Management Association of Reproductive Health Professionals www.arhp.org

  2. Expert Medical Advisory Committee • Herbert P. Brown, MD • Michelle Forcier, MD, MPH • Emily Godfrey, MD, MPH • Marji Gold, MD • Jini Tanenhaus, PA, MA Required Slide

  3. Learning Objectives • List four clinical indications for manual vacuum aspiration (MVA) • List four factors to consider when counseling women about MVA versus medical management of early pregnancy loss more…

  4. Learning Objectives (continued) • List three conditions in a patient that should cause a provider to use caution before providing MVA  or medical management of early pregnancy loss • List at least one medication regimen used for early medication abortion

  5. Module 1:MVA Overview

  6. Intended Unintended Pregnancy in the United States (2001) 6.3 million pregnancies 51% Unintended 51% 22% 22% Birth 49% 20% 20% Abortion 14% 7% 7% Fetal Loss Finer LB, Henshaw SK. Perspect Sex Reprod Health. 2006.

  7. Abortion 42% 44% Birth 14% Miscarriage/ Fetal Demise Outcomes of Unintended Pregnancies Approximately 3 million annually in the United States Finer LB, Henshaw SK. Perspect Sex Reprod Health. 2006.

  8. 1% Weeks Gestation 4% 6% ≤8 9 to 10 10% 11 to 12 13 to 15 61% 16 to 20 18% ≥21 Abortions by Length of Pregnancy Strauss LT, et al. MMWR. 2006

  9. What Is a Manual Vacuum Aspirator? • Manual vacuum aspirator • Has locking valve • Is portable and reusable • Vacuum is equivalent to electric pump • Efficacy is same as electric vacuum (98%–99%) • Has semi-flexible plastic cannula Creinin MD, et al. Obstet Gynecol Surv. 2001.; Goldberg AB, et al. Obstet Gynecol. 2004.’ Hemlin J, et al. Acta Obstet Gynecol Scand. 2001.

  10. What Is an Electric Vacuum Aspirator? • Electric vacuum aspirator • Uses an electric pump or suction machine connected via flexible tubing • Has a plastic or metal cannula • Typically used in centralized settings with high caseloads Creinin MD, et al. Obstet Gynecol Surv. 2001.; Goldberg AB, et al. Obstet Gynecol. 2004.; Hemlin J, et al. Acta Obstet Gynecol Scand. 2001.

  11. History of MVA 1973: Helms Amendment enacted 1980s: MVA marketed worldwide 1990s: MVA used in >100 countries 1973: USAID sponsors Ipas Bird ST, et al. Contraception. 2003.; Edwards J, et al. Curr Probl Obstet Gynecol Fertil. 1997.; Karman H, et al. Lancet. 1972.

  12. Comparison of EVA to MVA Dean G, et al. Contraception. 2003.

  13. Electric Suction Machine MVA Aspirator Products of Conception (POC) Procedure is complete when POC are identified Edwards J, et al. Am J Obstet Gynecol. 1997. MacIsaac L, et al. Am J Obstet Gynecol. 2000.

  14. Clinical Indications for MVA • Uterine evacuation in the first trimester: • Induced abortion • Spontaneous abortion • Incomplete medication abortion • Uterine sampling • Post-abortal hematometra Creinin MD, et al. Obstet Gynecol Surv. 2001.; Edwards J, Creinin MD. Curr Probl Obstet Gynecol Fertil.1997.; Castleman LD et al. Contraception. 2006; MVA Label. Ipas. 2007.

  15. Complications with MVA • Very rare • Same as EVA • May include: • Incomplete evacuation • Uterine or cervical injury • Infection • Hemorrhage • Vagal reaction MVA Label. Ipas. 2004.

  16. Putting Abortion into Perspective… Gold RB, Richards C. Issues Sci Technol.1990.; Hatcher RA. Contracept Technol Update.1998.; Mokdad AH, et al. MMWR Recomm Rep.2003.

  17. Post-Abortion Care • Women desiring pregnancy • Vitamin and diet recommendations • Toxic-exposure avoidance guidelines • Women avoiding pregnancy • Contraceptive counseling • Contraception initiated on day of MVA Creinin MD, et al. Obstet Gynecol Surv. 2001.; Goldberg AB, et al. Obstet Gynecol. 2004.; Hemlin J, Moller B. Acta Obstet Gynecol Scand. 2001.

  18. MVA vs. EVA Complication Rates Methods • Vacuum aspiration for abortion up to 10 wks LMP • Retrospective cohort analysis • Choice of method (MVA vs. EVA) up to physician • n = 1,002 for MVA; n = 724 for EVA • Charts reviewed for complications more… Goldberg AB, et al. Obstet Gynecol. 2004.

  19. Complications • 2.5% for MVA • 2.1% for EVA (p = 0.56) • No significant difference MVA vs. EVA Complication Rates (continued) more… *Elective not spontaneous studies Goldberg AB, et al. Obstet Gynecol. 2004.

  20. Choice of MVA vs EVA in procedures • Attendings: 52% MVA • Gyn residents: 59% MVA • Other residents: 76% MVA (p<0.001) MVA vs. EVA Complication Rates (continued) *Elective not spontaneous studies Goldberg AB, et al. Obstet Gynecol. 2004.

  21. Conventional Wisdom and Abortion Care 1970s Today • Wait 7+ weeks for lowest risk of complications • Ultra-sensitive pregnancy tests • POC inspection • Ultrasound • Medication abortion • MVA • No reason to wait Depineres T, Stewart F. NAF. 2002. ; Castadot RG. Fertil Steril. 1986. Edwards J, Creinin MD. Curr Probl Obstet Gynecol Fertil. 1997.

  22. What Services Do You Provide? Use index cards provided to answer the following. Do not write your name. • Does your facility currently provide vacuum aspiration abortions before 6 weeks? • Yes/No • Are there clinical or program-related barriers to providing early abortion with vacuum aspiration? • Yes/No (If yes, list the most significant barriers.)

  23. Gestational Age Strongest risk factor for abortion-related mortality Earlier Procedures Are Safer Abortions at <8 weeks = lowest risk of death Bartlet L, et al. Obstet Gynecol. 2004.

  24. Offering Services as Early as Possible “…Because access to abortions even one week earlier reduces the risk of death…increased access to early abortion services may increase the proportion of abortions performed at the lower-risk, early gestational ages and help reduce maternal deaths.” ‘ ‘ Bartlet L, et al. Obstet Gynecol. 2004.

  25. Early Abortion with Vacuum Aspiration Baird TL, Flinn SK. 2001.; Edwards J, Carson SA. Am J Obstet Gynecol. 1997. Edwards J, Creinin MD. Curr Probl Obstet Gynecol Fertil. 1997. Hemlin J, Moller B. Acta Obstet Gynecol Scand. 2001.; Paul ME, et al. Am J Obstet Gynecol. 2002.

  26. Early Abortion with MVA: Study • Methods • 2,399 MVA procedures, < 6 weeks LMP • Meticulous inspection of POC immediately after MVA • Results • 99.2% effective in terminating pregnancy • 6 repeat aspirations (0.25%) • 14 ectopic pregnancies (0.6%) diagnosed and treated Edwards J, Creinin MD. Curr Probl OIbstet Gynecol Fertil. 1997.

  27. Early Abortion with MVA or EVA: Study Methods • 1,132 women, ≤ 6 weeks LMP • Of 1,093 procedures: • 52% MVA • 40% EVA • 8% both • Examination of POC immediately after procedure more… Paul ME, et al. Am J Obstet Gynecol. 2002.

  28. Early Abortion with MVA or EVA: Study (continued) • Results 17 of 1,132 Required re-aspiration 2.3% of study population more… Paul ME, et al. Am J Obstet Gynecol. 2002.

  29. Early Abortion with MVA or EVA: Study (continued) Failure rates by technique among women with follow-up (95% CI): 1.1% 2.9% 7.5% (1.4%-5.7%) (0.4%-3.0%) (2.1%-18.2%) Both used MVA EVA more… Paul ME, et al. Am J Obstet Gynecol. 2002.

  30. Early Abortion with MVA or EVA: Study (continued) Of the 750 women with follow-up, 13 experienced other complications: • 4 incomplete abortions • 2 unrecognized ectopic pregnancies • 1 hematometra • 4 pelvic infections • 3 re-aspirations for pain and bleeding despite negative pathology Paul ME, et al. Am J Obstet Gynecol. 2002.

  31. MVA and POC: Study • In group overall • n = 1,726, up to 10 weeks LMP • Complication rates between MVA and EVA • 37 patients at < 6 weeks’ gestation • In 35 of 37, provider chose MVA • No re-aspirations needed in patients < 6 weeks more… Goldberg AB, et al. Obstet Gynecol. 2004.

  32. MVA and POC: Study (continued) ‘ ‘ “…Significantly more re-aspirations for inability to accurately identify the pregnancy occurred in electric group.” Goldberg AB et al. Obstet Gynecol, 2004 Goldberg AB, et al. Obstet Gynecol. 2004.

  33. Safety and Efficacy: Family Practice Office Methods • Abortion using MVA, <12 weeks LMP • Retrospective chart review, N = 1,677 • 60% performed by residents under supervision • 40% performed by attendings more… Westfall JM, et al. Arch Fam Med. 1998.

  34. Safety and Efficacy: Family Practice Office (continued) Results • 99.5% effective • 1.3% minor complications • No hospitalizations Westfall JM, et al. Arch Fam Med. 1998.

  35. Patient Satisfaction • Both EVA and MVA groups were highly satisfied • No differences in: • Pain • Anxiety • Bleeding • Acceptability • Satisfaction • More EVA patients were bothered by noise Bird ST, et al. Contraception. 2003.; Dean G, et al. Contraception. 2003.; Edelman A, et al. Am J Obstet Gynecol. 2001.

  36. MVA is simple Easily incorporated into office setting Training/Practice Issues Expanding pain management options Ultrasound as needed No sharp curettage Patient-provider interaction Identifying products of conception Instrument processing for multiple use MVA Safety and Efficacy: Summary

  37. MVA in Office Settings • Safety and efficacy equivalent to EVA • Portable • Simple • Low cost • Small and quiet Beneficial to incorporate MVA servicesinto the office setting. Goldberg AB, et al. Obstet Gynecol. 2004.

  38. Module 2:MVA Procedure

  39. Gather required supplies Charge aspirator Stabilize and anesthetizecervix Insert cannula Empty uterus MVA Steps After counseling and support …

  40. MVA Instruments

  41. Steps for Performing MVA A step-by-step, one- page poster is available from the manufacturer to guide clinicians through the procedure

  42. MVA and Pain Pain is made worse by: • Fearfulness • Anxiety • Depression Belanger E, et al. Pain. 1989.; Smith GM, et al. Am J Obstet Gynecol. 1979. Hansen GR, Streltzer J. Emerg Med Clin N Am. 2005.

  43. Effective Pain Management • Respectful, informed, and supportive staff • Warm, friendly environment • Gentle operative technique • Women’s involvement • Effective pain medications

  44. Pain Management Philosophies • Minimize risk/maximize benefit • Take away all pain/all feeling • Get through it

  45. 10% 32% 58% Pain Management Techniques With addition of: • Focused breathing: 76% • Visualization: 31% • Localized massage: 14% General or nitrous Local + IV Local Lichtengerg ES, et al. Contraception. 2001. Good M, et al. Pain Manag Nurs. 2002.

  46. Paracervical Block Deep Injection Regular Injection Castleman L, Mann C. 2002. Maltzer DS, et al. 1999.

  47. Efficacy of Ancillary Anesthesia • Importance of psychological preparation and support • Music as analgesia for abortion patients receiving paracervical block • 85% who wore headphones rated pain as “0,” compared with 52% of controls • Verbicaine (“Vocal Local”)/Distraction Therapy Shapiro AG, Cohen H. Contraception. 1975. Stubblefield PG.Suppl Int J Gynecol Obstet. 1989.

  48. Sharp Curettage and Pain • Often requires increased dilatation • Often painful • More difficult to reduce anesthesia Forna F, Gulmezoglu AM. Cochrane Library. 2002.

  49. Sharp Curettage and MVA • Generally not indicated • Not routinely recommended after MVA more… WHO. 2003

  50. Sharp Curettage and MVA (continued) ‘ ‘ “…Health managers and policy makers should make all possible efforts to replace sharp curettage (D&C) with vacuum aspiration.” WHO, 2003 WHO, Safe Abortion: Technical and Policy Guidance for Health Systems. 2003.

More Related